International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-4 : 431-434 doi: 10.5281/zenodo.16761837
Original Article
The Comparison of Dexmedetomidine Vs Dexamethasone as Adjuvants in Ultrasound Guided Supraclavicular Brachial Plexus Block in Upper Limb Surgeries
 ,
 ,
 ,
 ,
Published
July 17, 2025
Abstract

The clinical utility of local anaesthesia with adjuvant provides excellent nerve block with prolonged duration and faster action onset. There are various approaches for giving brachial plexus block among which supraclavicular plexus block is commonly used for upper limb surgeries. This study focuses on comparing the effects of dexmedetomidine and dexamethasone as adjuvants in ultrasound guided supraclavicular brachial plexus block. A total of 150 ASA (American society of anaesthesiologist) grade 1 and 2 patients aged 18-60 undergoing upper limb surgery were divided into two groups according to randomised double blind study - Group A given 20 mL of 0.5% Bupivacaine with 50 mcg (0.5ml) of dexmedetomidine and Group B given 20 mL of 0.5% Bupivacaine with dexamethasone 8mg (2ml). In both groups, 0.9% normal saline was added to make a total volume of 25 mL. Onset and duration of sensory and motor blocks, along with intraoperative analgesia quality were evaluated. The onset of sensory blocks was faster in patients in group A as compared to group B patients. In terms of duration of block, sensory and motor block and in terms of duration for post op analgesia were maintained for longer duration in Group A patient compared to group B patient.

Recommended Articles
Loading Image...
Volume-6, Issue-4
Citations
1383 Views
133 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved